Ashland reported Q1 fiscal 2026 sales of $386 million, down 5%, with the Avoca divestiture cutting sales by $10 million (2%). It posted a $14 million loss from continuing operations (-$0.30 EPS) and narrowed full-year Adjusted EBITDA guidance to $400–420 million due to Calvert City startup and weather delays.